FDA Grants 510(k) Clearance for Blue Belt Technologies’ STRIDE Knee Implant

Blue Belt Technologies received 510(k) clearance from the U.S. Food and Drug Administration for its STRIDE Unicondylar Knee implant.

Advertisement

The STRIDE implant will be marketed with the company’s NavioPFS system. The knee system is designed to treat medial and lateral compartment osteoarthritis.

More Articles on Devices:
TranS1 Renamed Baxano Surgical, Relocates Headquarters to Raleigh
SI-BONE Releases Data on 5,319 Patients Treated With iFuse Implant System
6 Device Company Acquisitions & Partnerships

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.